WallStreetZenWallStreetZen

NASDAQ: FENC
Fennec Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Fennec Pharmaceuticals earnings were -$12.0M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest FENC earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$3.2M, up 170.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, FENC reported annual earnings of -$436.0k, with -97.3% growth. The next FENC earnings date is Nov 6, 2025.

FENC earnings history

Current Revenue
$33.3M
Current Earnings
-$12.0M
Current Profit Margin
-36.1%

FENC Return on Equity

Current Company
N/A
Current Industry
-10.1%
Current Market
30.7%

FENC undefined

Current Company
-24.7%
Current Industry
-0.2%
FENC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when FENC announces earnings.

FENC undefined

Current Company
-23.3%
Current Industry
6.4%
FENC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FENC vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
FENC-$9.19M-$12.04MN/A-$0.44
CCCC-$102.90M-$111.58MN/A-$1.58
HUMA-$40.80M-$58.66MN/A-$0.45
TNXP-$79.44M-$81.42MN/A$259.70
IMMPN/A-$40.15MN/A-$0.28
View Top Biotech Stocks

FENC earnings dates

Next earnings date
Nov 6, 2025

Fennec Pharmaceuticals Earnings Reports & History FAQ

What were Fennec Pharmaceuticals's earnings last quarter?

On FENC's earnings call on Invalid Date, Fennec Pharmaceuticals (NASDAQ: FENC) reported Q2 2025 earnings per share (EPS) of -$0.11, up 45% year over year. Total FENC earnings for the quarter were -$3.15 million. In the same quarter last year, Fennec Pharmaceuticals's earnings per share (EPS) was -$0.20.

If you're new to stock investing, here's how to buy Fennec Pharmaceuticals stock.

When does Fennec Pharmaceuticals report earnings?

The next FENC earnings call is Invalid Date. Add FENC to your watchlist to be reminded of Fennec Pharmaceuticals's next earnings date.

Is Fennec Pharmaceuticals profitable or losing money?

As of the last Fennec Pharmaceuticals earnings report, Fennec Pharmaceuticals is currently losing money. Fennec Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$12.04 million, a 540.11% decrease year over year.

What was FENC's earnings growth in the past year?

As of Fennec Pharmaceuticals's earnings date in Invalid Date, Fennec Pharmaceuticals's earnings has grown year over year. FENC earnings in the past year totalled -$12.04 million.

What are Fennec Pharmaceuticals's earnings expectations?

The current EPS estimate for Fennec Pharmaceuticals's earnings report in Invalid Date is $0.08.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.